Franco-Indian Pharmaceuticals

Mumbai, India
Pharmaceutical manufacturing, formulation development, and global distribution of medications in India.
Annual revenue $119.3M Latest available
Total funding - Funding intelligence
Employees 1524 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Franco-Indian Pharmaceuticals

Franco-Indian Pharmaceuticals is a company based in Mumbai (India). The company has 1,524 employees as of April 07, 2024. Franco-Indian Pharmaceuticals offers products and services including Oral Penicillin V and Metformin.

  • Headquarter Mumbai, India
  • Employees 1524 as on 07 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Franco-Indian Pharmaceuticals Pvt. Ltd.
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $119.31 M (USD)
    -0.21
    as on Mar 31, 2023
  • Net Profit
    $8.9 M (USD)
    91.95
    as on Mar 31, 2023
  • EBITDA
    $13.75 M (USD)
    98.44
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1524

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Franco-Indian Pharmaceuticals

Franco-Indian Pharmaceuticals offers a comprehensive portfolio of products and services, including Oral Penicillin V and Metformin.

Product name locked
Category locked
Primary

This product was introduced as the first oral Penicillin in India and is utilized for treating bacterial infections.

Product name locked
Category locked
Locked

Metformin is provided as an economical treatment option for Diabetes and is part of a well-known range in the market.

Funding Insights of Franco-Indian Pharmaceuticals

Premium access

Detailed funding history for Franco-Indian Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Franco-Indian Pharmaceuticals

Investments
Premium access

Investment portfolio details for Franco-Indian Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Franco-Indian Pharmaceuticals

Premium access

Detailed financials for Franco-Indian Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Franco-Indian Pharmaceuticals Comparisons

Franco-Indian Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing, formulation development, and g...
Location
Mumbai, India
Founded Year
-
Annual Revenue
$119.31 M (USD)
Net Profit
$8.9 M (USD)
EBITDA
$13.75 M (USD)
Employees
1,524
As of 2024
Premium access

Peer comparison for Franco-Indian Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Franco-Indian Pharmaceuticals

Premium access

Detailed competitors of Franco-Indian Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Franco-Indian Pharmaceuticals

Premium access

Complete news archive for Franco-Indian Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Franco-Indian Pharmaceuticals

Franco-Indian Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Apr 07, 2024, the latest employee count at Franco-Indian Pharmaceuticals is 1,524.

Annual revenue of Franco-Indian Pharmaceuticals is $119.31M as on Mar 31, 2023.

Franco-Indian Pharmaceuticals Pvt. Ltd. was established in 1949 and is noted for its contributions to accessible healthcare through the introduction of key medications like oral Penicillin V and Cortisone. A workforce of nearly 2000 employees is maintained, with operations spanning manufacturing and research facilities in Mumbai. Exports to Asia, Africa, and other regions are handled via distribution networks, while a portfolio exceeding 400 crore in turnover includes brands for diabetes and respiratory care. Integrity and excellence are upheld in its practices, ensuring quality and affordability in pharmaceutical offerings.

Franco-Indian Pharmaceuticals offers Oral Penicillin V and Metformin.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available